Latest News

Antibiotics used in newborns despite low risk for sepsis


 

FROM PEDIATRICS

Data inform intelligent antibiotic use

“Early-onset sepsis is predominantly caused by exposure of the fetus or neonate to ascending maternal colonization or infection by gastrointestinal or genitourinary bacteria,” Iris Krishna, MD, of Emory University, Atlanta, said in an interview. “Scenarios where there is limited neonatal exposure to these organisms would decrease the risk of development of EOS, therefore it is not surprising that delivery characteristics of low-risk deliveries as defined by investigators – the absence of labor, absence of intra-amniotic infection, rupture of membranes at time of delivery, and cesarean delivery – would have resulted in decreased likelihood of EOS.”

Inappropriate antibiotic use contributes to the development of resistant and more virulent strains of bacteria. A growing body of literature also suggests that early antibiotic usage in newborns may affect the neonatal gut microbiome, which is important for development of the neonatal immune system. Early alterations of the microbiome may have long-term implications,” Dr. Krishna said.

“Understanding the delivery characteristics that increase the risk of EOS are crucial to optimizing the use of antibiotics and thereby minimize potential harm to newborns,” she said. “Studies such as the current study are needed develop EOS prediction tools to improve antibiotic utilization.” More research is needed not only to adequately predict EOS, but to explore how antibiotics affect the neonatal microbiome, and how clinicians can circumvent potential adverse implications with antibiotic use to improve long-term health, Dr. Krishna concluded.

The study received no outside funding. The researchers had no financial conflicts to disclose. Dr. Krishna had no financial conflicts to disclose and serves on the editorial advisory board of Ob.Gyn. News.

Pages

Recommended Reading

Despite strict controls, some infants born to mothers with COVID-19 appear infected
Journal of Clinical Outcomes Management
Reports suggest possible in utero transmission of novel coronavirus 2019
Journal of Clinical Outcomes Management
AAP issues guidance on managing infants born to mothers with COVID-19
Journal of Clinical Outcomes Management
COVID-19 may increase risk of preterm birth and cesarean delivery
Journal of Clinical Outcomes Management
Ob.gyns. struggle to keep pace with changing COVID-19 knowledge
Journal of Clinical Outcomes Management
Small NY study: Mother-baby transmission of COVID-19 not seen
Journal of Clinical Outcomes Management
Metformin improves most outcomes for T2D during pregnancy
Journal of Clinical Outcomes Management
Maternal COVID antibodies cross placenta, detected in newborns
Journal of Clinical Outcomes Management
COVID-19 linked to baby bust in high-income countries
Journal of Clinical Outcomes Management
Booster recommendations for pregnant women, teens, and other groups explained
Journal of Clinical Outcomes Management